PCM
WST icon

Price Capital Management’s West Pharmaceutical WST Stock Holding History

Price Capital Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-12,168
Closed -$733K – 217
2015
Q1 		$733K Sell
12,168
-15,995
-57% -$852K 0.45% 31
2014
Q4 		$1.5M Buy
+28,163
New +$1.41M 1.32% 34

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KI
Kalmar Investments Greenville, Delaware $443M AUM 23.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Price Capital Management's WST Position: Q2 2015 in Review

Price Capital Management sold out of West Pharmaceutical (WST) in Q2 2015, closing a stake of 12,168 shares — an estimated $733K sold.

Price Capital Management first reported a position in WST in Q4 2014 and held it in 2 quarters. The position peaked at $1.5M in Q4 2014. 218 funds tracked by Wall St. Rank hold WST as of Q2 2015.

  • Price Capital Management reported no remaining West Pharmaceutical position as of Q2 2015 after selling out during the quarter.
  • Price Capital Management sold 12,168 West Pharmaceutical shares in Q2 2015, an estimated $733K.
  • Price Capital Management first reported a position in West Pharmaceutical in Q4 2014 and held it in 2 quarters.
  • Price Capital Management's West Pharmaceutical position peaked at $1.5M in Q4 2014.
  • 218 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2015.

Based on Price Capital Management's 13F filing for Q2 2015.